A few things with ARYC: first of all, they have not been current on their filings since 2014. However, they are extremely active in communicating through twitter and have welcomed investors for corporate/facility tours. They are generating revenues and recently gave revenue guidance of $2m/wk for their allergy test. Finally, there is anticipation of release of financials soon.
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links